Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

Masking and Visitation Changes: Due to high rates of respiratory illnesses in our community, we’ve made changes to our masking and visitation guidelines .

Current Research Studies

SkyPASS: A prospective, non-interventional (NIS), long-term, post-authorisation safety study (PASS) of patients treated with lonapegsomatropin.

ASND0033 SkyPASS

Clinicaltrials.gov ID: NCT05775523

What is the goal of the study?

This prospective, non-interventional, long-term, post-authorisation safety study of patients treated with lonapegsomatropin will seek to further assess the important potential risks (neoplasms, type 2 diabetes mellitus) and the missing information (long-term safety including adverse drug reactions potentially related to methoxypolyethylene glycol (mPEG) exposure) as per the Risk Management Plan (RMP). This study is a required regulatory study within the RMP.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Patricia Fechner
Study Team Member: ECR Endocrine Research, [email protected]